Drug Discovery Outsourcing Trends and Forecast
The future of the global drug discovery outsourcing market looks promising with opportunities in the pharmaceutical and biotechnology company and academic institute markets. The global drug discovery outsourcing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are increasing global trend of collaborations in drug discovery research, rising rates of genetic, metabolic, and other chronic illnesses, as well as improvements in drug discovery technologies, and significant presence of top biotechnology and pharmaceutical firms.Drug Discovery Outsourcing by Segment
The study includes a forecast for the global drug discovery outsourcing by drug type, workflow, therapeutic area, end use, and region.Drug Discovery Outsourcing Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:
- Small Molecules
- Large Molecules
Drug Discovery Outsourcing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
- Target Identification & Screening
- Target Validation & Functional Informatics
- Lead Identification & Candidate Optimization
- Preclinical Development
- Other Associated Workflow
Drug Discovery Outsourcing Market by Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:
- Cardiovascular
- Central Nervous System (CNS)
- Gastrointestinal
- Hematology
- Respiratory System
- Infectious Disease
- Oncology
- Immunology
- Others
Drug Discovery Outsourcing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Pharmaceutical And Biotechnology Companies
- Academic Institutes
- Others
Drug Discovery Outsourcing Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Drug Discovery Outsourcing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery outsourcing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery outsourcing companies profiled in this report include:- Albany Molecular Research
- EVOTEC
- GenScript
- Pharmaceutical Product Development
- Charles River
- WuXi AppTec
- Merck & Co
- Thermo Fisher Scientific
- Dalton Pharma Services
- Oncodesign
Drug Discovery Outsourcing Market Insights
The report forecasts that small molecules will remain the larger segment over the forecast period due to rapid advancement of biopharmaceutical research and technology for the discovery and some distinct advantages, such as it can be administered orally and can pass through cell membranes to reach intracellular targets more precisely as compared to large molecules.Within this market, pharmaceutical and biotechnology companies is expected to witness higher growth due to growing rate of pipeline therapeutics, along with the pharmaceutical and biopharmaceutical firms' increasing R&D spending.
North America is expected to witness the highest growth over the forecast period due to high adoption rate of technologically advanced AI-based drug discovery systems, increase in healthcare expenditure, and presence of significant key firms in the country providing outsourcing services for the creation of novel pharmacological therapies to treat cancer and chronic diseases.
Features of the Global Drug Discovery Outsourcing Market
- Market Size Estimates: Drug discovery outsourcing market size estimation in terms of value ($B).- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Drug discovery outsourcing market size by drug type, workflow, therapeutic area, end use, and region in terms of value ($B).
- Regional Analysis: Drug discovery outsourcing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different drug type, workflow, therapeutic area, end use, and regions for the drug discovery outsourcing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discovery outsourcing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the drug discovery outsourcing market size?Answer: The global drug discovery outsourcing market is expected to reach an estimated $6.1 billion by 2030.
Q2. What is the growth forecast for drug discovery outsourcing market?
Answer: The global drug discovery outsourcing market is expected to grow with a CAGR of 7.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the drug discovery outsourcing market?
Answer: The major drivers for this market are increasing global trend of collaborations in drug discovery research, rising rates of genetic, metabolic, and other chronic illnesses, as well as improvements in drug discovery technologies, and significant presence of top biotechnology and pharmaceutical firms.
Q4. What are the major segments for drug discovery outsourcing market?
Answer: The future of the global drug discovery outsourcing market looks promising with opportunities in the pharmaceutical and biotechnology company and academic institute markets.
Q5. Who are the key drug discovery outsourcing market companies?
Answer: Some of the key drug discovery outsourcing companies are as follows:
- Albany Molecular Research
- EVOTEC
- GenScript
- Pharmaceutical Product Development
- Charles River
- WuXi AppTec
- Merck & Co
- Thermo Fisher Scientific
- Dalton Pharma Services
- Oncodesign
Answer: The report forecasts that small molecules will remain the larger segment over the forecast period due to rapid advancement of biopharmaceutical research and technology for the discovery and some distinct advantages, such as it can be administered orally and can pass through cell membranes to reach intracellular targets more precisely as compared to large molecules.
Q7. In drug discovery outsourcing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to high adoption rate of technologically advanced AI-based drug discovery systems, increase in healthcare expenditure, and presence of significant key firms in the country providing outsourcing services for the creation of novel pharmacological therapies to treat cancer and chronic diseases.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisherl provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the drug discovery outsourcing market by drug type (small molecules and large molecules), workflow (target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, and other associated workflow), therapeutic area (cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory system, infectious disease, oncology, immunology, and others), end use (pharmaceutical and biotechnology companies, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Drug Discovery Outsourcing Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Albany Molecular Research
- EVOTEC
- GenScript
- Pharmaceutical Product Development
- Charles River
- WuXi AppTec
- Merck & Co
- Thermo Fisher Scientific
- Dalton Pharma Services
- Oncodesign
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
